Institute for Clinical and Experimental Medicine

ikem.cz

Total trials

60

Active

17

Phase 3

5

Total enrollment

14,766

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Heart Failure6
  • Insulin Resistance5
  • Kidney Transplantation5
  • Gastroparesis4
  • Type 2 Diabetes4
  • Diabetes Mellitus, Type 13
  • Atrial Fibrillation3
  • Cardiovascular Diseases3

Frequently asked questions about Institute for Clinical and Experimental Medicine

How many clinical trials does Institute for Clinical and Experimental Medicine have on ClinicalTrials.gov?
Institute for Clinical and Experimental Medicine is listed as the lead sponsor on 60 clinical trials in ClinicalTrials.gov, 17 of which are currently active (recruiting, enrolling, or ongoing).
How many of Institute for Clinical and Experimental Medicine's trials are in Phase 3?
5 of Institute for Clinical and Experimental Medicine's trials are in Phase 3.
What therapeutic areas does Institute for Clinical and Experimental Medicine focus on?
Institute for Clinical and Experimental Medicine's most-studied conditions on ClinicalTrials.gov are Heart Failure, Insulin Resistance, Kidney Transplantation, Gastroparesis, Type 2 Diabetes.